AR231533A1 - Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida - Google Patents

Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida

Info

Publication number
AR231533A1
AR231533A1 AR290026A AR29002682A AR231533A1 AR 231533 A1 AR231533 A1 AR 231533A1 AR 290026 A AR290026 A AR 290026A AR 29002682 A AR29002682 A AR 29002682A AR 231533 A1 AR231533 A1 AR 231533A1
Authority
AR
Argentina
Prior art keywords
alquel
indol
methane
amino
preparing
Prior art date
Application number
AR290026A
Other languages
English (en)
Spanish (es)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of AR231533A1 publication Critical patent/AR231533A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR290026A 1980-08-12 1982-07-20 Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida AR231533A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8026288 1980-08-12

Publications (1)

Publication Number Publication Date
AR231533A1 true AR231533A1 (es) 1984-12-28

Family

ID=10515412

Family Applications (1)

Application Number Title Priority Date Filing Date
AR290026A AR231533A1 (es) 1980-08-12 1982-07-20 Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida

Country Status (28)

Country Link
US (2) US4672067A (ru)
JP (1) JPS5759864A (ru)
AR (1) AR231533A1 (ru)
AT (1) AT381304B (ru)
AU (1) AU548270B2 (ru)
BE (1) BE889930A (ru)
CA (2) CA1169429A (ru)
CH (1) CH651550A5 (ru)
DE (1) DE3131748A1 (ru)
DK (1) DK157680C (ru)
ES (2) ES8300700A1 (ru)
FI (1) FI812475L (ru)
FR (1) FR2488605A1 (ru)
GB (1) GB2081717B (ru)
GR (1) GR74536B (ru)
IE (1) IE51492B1 (ru)
IL (1) IL63541A (ru)
IT (1) IT1171451B (ru)
LU (1) LU83546A1 (ru)
MY (1) MY8600577A (ru)
NL (1) NL8103768A (ru)
NO (1) NO812722L (ru)
NZ (1) NZ197997A (ru)
PH (1) PH17428A (ru)
PT (1) PT73503B (ru)
SE (1) SE454881B (ru)
ZA (1) ZA815539B (ru)
ZW (1) ZW19381A1 (ru)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79215B (ru) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332434D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Production of chemical compounds
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
GB8607824D0 (en) * 1986-03-27 1986-04-30 Glaxo Group Ltd Chemical compounds
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide
GB8615599D0 (en) * 1986-06-26 1986-07-30 Glaxo Group Ltd Chemical compounds
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
SI21560B (sl) * 1990-06-07 2005-04-30 Astrazeneca Ab 3,5-disubstituirani indolni derivati kot "5-HT1-podobni" receptorski agonisti
GB9022250D0 (en) * 1990-10-12 1990-11-28 Glaxo Group Ltd Medicaments
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
WO1992006973A1 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
ES2033577B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de la 2-carboxi-3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida y sus esteres alquilicos inferiores.
ES2033578B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida.
GB9209882D0 (en) * 1992-05-07 1992-06-24 Glaxo Lab Sa Compositions
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
CZ59996A3 (en) * 1993-08-31 1996-06-12 Pfizer 5-arylindole derivatives per se and for treating diseases, intermediates for their preparation and pharmaceutical compositions based thereon
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
JPH11513666A (ja) * 1995-10-10 1999-11-24 イーライ・リリー・アンド・カンパニー Ｎ−［２−置換−３−（２−アミノエチル）−１ｈ−インドール−５−イル］−アミド：新規５−ｈｔ▲下１ｆ▼作動剤
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
WO2002079153A1 (en) * 2001-03-28 2002-10-10 Biocatalytics, Inc. Method for producing tryptamine derivatives
KR20090003374A (ko) * 2001-04-13 2009-01-09 오르가노 가부시키가이샤 이온교환체
KR20130136010A (ko) * 2005-04-13 2013-12-11 네우렉슨 인코포레이티드 Ｎｏｓ 저해 활성을 갖는 치환된 인돌 화합물
CA2991108A1 (en) 2015-07-02 2017-01-05 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870162A (en) * 1954-04-28 1959-01-20 Upjohn Co Production of certain tryptamines and compounds produced in the process
BE632051A (fr) * 1963-05-08 1963-11-18 Sandoz Sa Nouveaux dérivés de l'indole et leur préparation.
CH442303A (de) * 1964-06-26 1967-08-31 Sandoz Ag Verfahren zur Herstellung von neuen Indol-Derivaten
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
US4180509A (en) * 1977-07-01 1979-12-25 Merrell Toraude Et Compagnie α-Ethynyl tryptophanes
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
SE454881B (sv) 1988-06-06
ES504695A0 (es) 1982-11-01
SE8104782L (sv) 1982-02-13
ES513935A0 (es) 1984-04-16
IL63541A (en) 1985-08-30
ES8300700A1 (es) 1982-11-01
NL8103768A (nl) 1982-03-01
JPH0148895B2 (ru) 1989-10-20
JPS5759864A (en) 1982-04-10
IE51492B1 (en) 1987-01-07
NZ197997A (en) 1985-08-16
IT1171451B (it) 1987-06-10
ZW19381A1 (en) 1983-03-09
CA1169077A (en) 1984-06-12
PT73503B (en) 1983-09-14
IT8149086A0 (it) 1981-08-11
GB2081717A (en) 1982-02-24
AU548270B2 (en) 1985-12-05
ZA815539B (en) 1983-03-30
DK157680B (da) 1990-02-05
US4672067A (en) 1987-06-09
GR74536B (ru) 1984-06-29
AU7399681A (en) 1982-02-18
BE889930A (fr) 1982-02-11
DE3131748C2 (ru) 1992-04-23
DE3131748A1 (de) 1982-04-01
CA1169429A (en) 1984-06-19
PH17428A (en) 1984-08-20
AT381304B (de) 1986-09-25
MY8600577A (en) 1986-12-31
DK357181A (da) 1982-02-13
ES8404327A1 (es) 1984-04-16
FI812475L (fi) 1982-02-13
GB2081717B (en) 1983-09-28
LU83546A1 (fr) 1983-06-08
CH651550A5 (fr) 1985-09-30
NO812722L (no) 1982-02-15
IE811831L (en) 1982-02-12
FR2488605B1 (ru) 1984-11-16
FR2488605A1 (fr) 1982-02-19
DK157680C (da) 1990-07-09
US4636521A (en) 1987-01-13
PT73503A (en) 1981-09-01
ATA352881A (de) 1986-02-15

Similar Documents

Publication Publication Date Title
AR231533A1 (es) Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida
ES520104A0 (es) Un procedimiento para preparar derivados de nicotinamida.
AR227533A1 (es) Un procedimiento para producir derivados fenetilaminicos sufamoil sustituidos
ES505373A0 (es) Un metodo para preparar derivados de fenilpiperazina
ES554546A0 (es) Un procedimiento para preparar derivados de guanina
ES530916A0 (es) Un procedimiento para preparar derivados de pirimidina
ES502276A0 (es) Procedimiento para preparar derivados de piridoxina
ES505898A0 (es) Procedimiento para preparar derivados de pirimidona
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES503091A0 (es) Un procedimiento para obtener derivados de benzopirano
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES528003A0 (es) Un procedimiento para preparar derivados de cefem
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES505656A0 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
ES502026A0 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ES507975A0 (es) Un metodo para preparar derivados de pirazolina.
ES500796A0 (es) Procedimiento para preparar derivados de pirimidona
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona
ES506302A0 (es) Un procedimiento para preparar derivados de tetrahidroiso- quinoleinas
ES500478A0 (es) Un procedimiento para obtener derivados de biciclooctano
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.
ES530855A0 (es) Un procedimiento para preparar derivados de benzotiazina